专题：Myasthenia Gravis and Thymoma

This cluster of papers focuses on the research related to myasthenia gravis, including its subgroups, clinical correlates, treatment strategies, and the role of autoantibodies. Additionally, it explores the classification and prognosis of thymic tumors, the efficacy of thymectomy, and the epidemiology of these conditions.
最新文献
Peer Review of “Localized Immune Cascade Programming in Desmoplastic Tumors: In Silico Modeling and Validation Study”

article Full Text OpenAlex

Peer Review of “Localized Immune Cascade Programming in Desmoplastic Tumors: In Silico Modeling and Validation Study”

article Full Text OpenAlex

When Central Tolerance Fails: Thymic Malignancies at the Intersection of Cancer Immunity and Autoimmunity

article Full Text OpenAlex

The Duke MG Patient Registry III . Comparative Effectiveness of Azathioprine and Mycophenolate Mofetil in Generalized Myasthenia Gravis, a Retrospective Single Center Review

article Full Text OpenAlex

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study

article Full Text OpenAlex

Rozanolixizumab-induced aseptic meningitis in AChR-thymoma associated myasthenia gravis

article Full Text OpenAlex

Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer

article Full Text OpenAlex

Diagnosis and management of acute neuromuscular weakness

article Full Text OpenAlex

Efgartigimod for Fetal Acetylcholine Receptor Antibody–Related Disorder

article Full Text OpenAlex

2026 CTP Reimbursement FAQs

article Full Text OpenAlex

近5年高被引文献
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

article Full Text OpenAlex 236 FWCI48.7381

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

article Full Text OpenAlex 228 FWCI53.1777

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

review Full Text OpenAlex 222 FWCI27.6606

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

article Full Text OpenAlex 219 FWCI45.8096

Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis

article Full Text OpenAlex 201 FWCI23.1745

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

article Full Text OpenAlex 179 FWCI19.9356

Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells

article Full Text OpenAlex 156 FWCI36.2089

Health Consequences of Thymus Removal in Adults

article Full Text OpenAlex 146 FWCI30.4351

Efgartigimod: First Approval

review Full Text OpenAlex 142 FWCI16.9432

Anti-CD19 CAR T cells for refractory myasthenia gravis

letter Full Text OpenAlex 136 FWCI28.3505